These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 7566982)
1. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Viglietto G; Chiappetta G; Martinez-Tello FJ; Fukunaga FH; Tallini G; Rigopoulou D; Visconti R; Mastro A; Santoro M; Fusco A Oncogene; 1995 Sep; 11(6):1207-10. PubMed ID: 7566982 [TBL] [Abstract][Full Text] [Related]
2. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Zou M; Shi Y; Farid NR Cancer; 1994 Jan; 73(1):176-80. PubMed ID: 8275421 [TBL] [Abstract][Full Text] [Related]
3. Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors. Namba H; Yamashita S; Pei HC; Ishikawa N; Villadolid MC; Tominaga T; Kimura H; Tsuruta M; Yokoyama N; Izumi M Endocrinol Jpn; 1991 Dec; 38(6):627-32. PubMed ID: 1823030 [TBL] [Abstract][Full Text] [Related]
4. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903 [TBL] [Abstract][Full Text] [Related]
5. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638 [TBL] [Abstract][Full Text] [Related]
6. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas. Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668 [TBL] [Abstract][Full Text] [Related]
7. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261 [TBL] [Abstract][Full Text] [Related]
9. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704 [TBL] [Abstract][Full Text] [Related]
10. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781 [TBL] [Abstract][Full Text] [Related]
11. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913 [TBL] [Abstract][Full Text] [Related]
12. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation. Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350 [TBL] [Abstract][Full Text] [Related]
13. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340 [TBL] [Abstract][Full Text] [Related]
15. RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Williams GH; Rooney S; Thomas GA; Cummins G; Williams ED Br J Cancer; 1996 Aug; 74(4):585-9. PubMed ID: 8761374 [TBL] [Abstract][Full Text] [Related]
16. The ret/PTC oncogene in papillary thyroid carcinoma. Jhiang SM; Mazzaferri EL J Lab Clin Med; 1994 Mar; 123(3):331-7. PubMed ID: 8133143 [No Abstract] [Full Text] [Related]
17. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma. Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832 [TBL] [Abstract][Full Text] [Related]
18. Different significance of ret/PTC(1) and ret/PTC(3) rearrangements in thyroid carcinogenesis: lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation. Cetta F; Gori M; Montalto G; Zuckermann M; Toti P J Clin Endocrinol Metab; 2001 Mar; 86(3):1429. PubMed ID: 11238550 [No Abstract] [Full Text] [Related]
19. The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications. Komminoth P Virchows Arch; 1997 Jul; 431(1):1-9. PubMed ID: 9247627 [TBL] [Abstract][Full Text] [Related]
20. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Klugbauer S; Lengfelder E; Demidchik EP; Rabes HM Oncogene; 1995 Dec; 11(12):2459-67. PubMed ID: 8545102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]